Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: re: 10Q

Re: future, ok, but where is that stated, ttccrr

posted on Jan 18, 2007 09:59PM

It is PDS's (Phoenix Digital) expense. Not PTSC's.  PDS is a seperate entity that PTSC is 50% owner of.  The expenses are on their books, not PTSC's.   

PTSC only reports the net gain or loss of this investment. ( Maybe this is a reason why some potential investors can't quite figure out where PTSC earns there money???  It doesn't really show up as revenue.)

Corrections welcome.

Share
New Message
Please login to post a reply